Open Access · CC BY-NC 4.0
Beyond a Single KRAS Inhibitor: China-Originated Therapeutics and the Rise of Resistance-Directed Combinations
International Open Medical Journal (IOMJ) · 09.11.2026 · 2 · 255-258
DOI: 10.65364/iomj.2026.17 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Open Medical Journal (IOMJ), online erschienen am 09.11.2026. Verfasst von Yue Hao und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
none
Zitieren
APA
Hao, Y., & Song, Z. (2026). Beyond a Single KRAS Inhibitor: China-Originated Therapeutics and the Rise of Resistance-Directed Combinations. International Open Medical Journal (IOMJ), 2, 255-258. https://doi.org/10.65364/iomj.2026.17
Vancouver
Hao Y, Song Z. Beyond a Single KRAS Inhibitor: China-Originated Therapeutics and the Rise of Resistance-Directed Combinations. International Open Medical Journal (IOMJ). 2026;2:255-258. doi:10.65364/iomj.2026.17
BibTeX
@article{Hao2026,
author = {Hao, Yue and Song, Zhengbo},
title = {Beyond a Single KRAS Inhibitor: China-Originated Therapeutics and the Rise of Resistance-Directed Combinations},
journal = {International Open Medical Journal (IOMJ)},
year = {2026},
volume = {2},
pages = {255--258},
doi = {10.65364/iomj.2026.17}
}
EUVIMED